AKTX
Akari Therapeutics Announces Key Leadership Appointments
时间：2024-12-18 21:51:29 市场： 综合 美股
Akari Therapeutics Plc - Appoints Samir R. Patel as CEO
时间：2024-12-18 21:51:29 市场： 综合 美股
Akari Therapeutics Appoints Torsten Hombeck, Ph.d. as Chief Financial Officer
时间：2024-12-16 22:05:00 市场： 美股 综合
Akari Therapeutics Plc - Merger to Result in 50% Equity Ownership for Akari and Peak Bio Shareholders
时间：2024-11-08 21:00:02 市场： 美股 综合
Akari Therapeutics Announces Effectiveness of Form S-4 and General Meeting Date of November 7, 2024 Related to Peak Bio Merger
时间：2024-10-15 20:00:07 市场： 美股 综合
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; Poised to End Week Higher European equities traded in the US as American depositary receipts were moving higher late Friday morning, rising 0.82% to 1,443.36 on the S&P Europe Select ADR Index. The gain is helping the index end the week 1.2% higher.From continental Europe, the gainers were led by biotech firm BioNTech (BNTX) and biopharmaceutical firm Genfit (GNFT), which climbed 13% and 4.7%, respectively. They were followed by biotech firm Evaxion Biotech (EVAX) and pharmaceutical firm Ascendis Pharma (ASND), which increased 3.4% and 2.7%, respectively.The decliners from continental Europe were led by biopharmaceutical company Cellectis (CLLS) and accommodations booking site trivago (TRVG), which fell 2.1% and 1.1%, respectively. They were followed by telecommunications company VEON (VEON) and medical device maker EDAP TMS (EDAP), which were off 0.8% and 0.5%, respectively.From the UK and Irela
时间：2024-09-13 23:19:01 市场： 美股 综合
European Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading European equities traded in the US as American depositary receipts were moving lower late Wednesday morning as the S&P Europe Select ADR Index was down 0.31% to 1,406.11.From continental Europe, the gainers were led by biopharmaceutical companies Grifols (GRFS) and Cellectis (CLLS), which rose 5% and 3%, respectively. They were followed by biotech firm Evaxion Biotech (EVAX) and biopharmaceutical company Genfit (GNFT), which were up 2.8% and 2%, respectively.The decliners from continental Europe were led by furniture maker Natuzzi (NTZ) and biopharmaceutical company DBV Technologies (DBVT), which dropped 5.7% and 3.8%, respectively. They were followed by medical device maker EDAP TMS (EDAP) and telecommunications company Ericsson (ERIC), which fell 2.8% and 2.1%, respectively.From the UK and Ireland, the gainers were led by biopharmaceutical company Verona Pharma (VRNA), which increased
时间：2024-09-11 23:20:33 市场： 美股 综合